APPLICATION
ANDA090702
TYPE
ANDA
ORIGINAL APPROVAL
2009-09-25
LATEST ACTION
2021-10-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
LITHIUM CARBONATEPrescription
LITHIUM CARBONATE 300MG · CAPSULE · ORAL
LITHIUM CARBONATEPrescription
LITHIUM CARBONATE 600MG · CAPSULE · ORAL
LITHIUM CARBONATEPrescription
LITHIUM CARBONATE 150MG · CAPSULE · ORAL
Approval history
2021-10-01Labeling · Supplement 10 · standardAP
2021-10-01Labeling · Supplement 7 · standardAP
2018-05-03Labeling · Supplement 4 · standardAP
2012-03-06Labeling · Supplement 2AP
2009-09-25OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.